Biblio
Therapeutic effect of bortezomib for primary plasma cell leukemia followed by auto/allo stem cell transplantation. Int Med Case Rep J. 2012;5:39-43.
Elevation of early plasma biomarkers in patients with clinical risk factors predicts the increased nonrelapse mortality after allogeneic hematopoietic stem cell transplantation: Biomarkers for nonrelapse mortality. Transplant Cell Ther. 2021.
Association of High Mobility Group Box-Protein 1 and Platelet Microparticles in Patients After Hematopoietic Stem Cell Transplantation. Clin Appl Thromb Hemost. 2023;29:10760296231193398.
.